Showing results (1231-1240 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|May 3, 2015
Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic ModelsNeil Mathias, Yan Xu, Balvinder Vig, et al.The AAPS Journal|May 3, 2015
A Systematic Analysis of the Sensitivity of Plasma Pharmacokinetics to Detect Differences in the Pulmonary Performance of Inhaled Fluticasone Propionate Products Using a Model-Based Simulation ApproachBenjamin Weber, Guenther HochhausThe AAPS Journal|April 18, 2020
Development of a FRET-Based Assay for Analysis of mAbs Internalization and Processing by Dendritic Cells in Preclinical Immunogenicity Risk AssessmentYi Wen, Suntara Cahya, Wei Zeng, et al.The AAPS Journal|October 23, 2010
Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensisTien-Yuan Wu, Tin Oo Khor, Constance Lay Lay Saw, et al.The AAPS Journal|February 9, 2011
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects modelsMartin Bergstrand, Andrew C Hooker, Johan E Wallin, et al.The AAPS Journal|December 31, 2010
Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cellsPing Chen, Josephine Aimiuwu, Zhiliang Xie, et al.The AAPS Journal|January 7, 2011
Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosisBelén Valenzuela, Ricardo Nalda-Molina, Pere Bretcha-Boix, et al.The AAPS Journal|January 15, 2011
Human cannabinoid 1 GPCR C-terminal domain interacts with bilayer phospholipids to modulate the structure of its membrane environmentElvis K Tiburu, Sergiy Tyukhtenko, Han Zhou, et al.The AAPS Journal|January 20, 2011
The pharmacokinetic/pharmacodynamic pipeline: translating anticancer drug pharmacology to the clinicQingyu Zhou, James M GalloThe AAPS Journal|January 18, 2011
Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug developmentJean W Lee, Marian Kelley, Lindsay E King, et al.Pageof 235